Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-06T15:38:48.680Z Has data issue: false hasContentIssue false

Chapter 10 - Myopathies and the Parturient

Published online by Cambridge University Press:  26 January 2024

By
Britany L. Raymond  and
Jeanette R. Bauchat
Edited by
David R. Gambling ,
M. Joanne Douglas  and
Grace Lim
David R. Gambling
Affiliation:
University of California, San Diego
M. Joanne Douglas
Affiliation:
University of British Columbia, Vancouver
Grace Lim
Affiliation:
University of Pittsburgh
Get access

Summary

Myopathies are a group of clinical diseases that impair the function of skeletal muscle. The muscle fibers are affected directly, as the innervation and neuromuscular junctions remain intact. Although a primary symptom is often weakness, variable patterns of stiffness, contractures, or cramping may also be present. These symptoms are often exacerbated by the physiologic stress of pregnancy and labor, which may unmask a previously undiagnosed myopathy. The hereditary myopathies include muscular dystrophies, congenital myopathies, metabolic myopathies, and disorders of muscle membrane excitability. Inflammatory myopathies are a subset of acquired myopathy. Each classification has specific obstetric and anesthetic considerations, which will be described in detail.

Type
Chapter
Information
Obstetric Anesthesia and Uncommon Disorders , pp. 122 - 139
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barohn, RJ, Dimachkie, MM, Jackson, CE. A pattern recognition approach to patients with a suspected myopathy. Neurol Clin 2014;32:569–593.Google Scholar
Zagorda, B, Camdessanche, JP, Feasson, L. Pregnancy and myopathies: reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review. Rev Neurol (Paris) 2021;177:225–234.Google Scholar
Shieh, PB. Muscular dystrophies and other genetic myopathies. Neurol Clin 2013;31:1009–1029.Google Scholar
Narayanaswami, P, Weiss, M, Selcen, D, et al. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 2014;83:1453–1463.Google Scholar
Edmundson, C, Guidon, AC. Neuromuscular disorders in pregnancy. Semin Neurol 2017;37:643–652.Google Scholar
Johnson, NE. Myotonic muscular dystrophies. Continuum (Minneap Minn) 2019;25:1682–1695.Google Scholar
Mah, JK, Korngut, L, Fiest, KM, et al. A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 2016;43:163–177.Google Scholar
Boentert, M, Cao, M, Mass, D, et al. Consensus-based care recommendations for pulmonologists treating adults with myotonic dystrophy Type 1. Respiration 2020;99:360–368.Google Scholar
Schoser, B, Montagnese, F, Bassez, G, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 2. Neurol Clin Pract 2019;9:343–353.Google Scholar
Argov, Z, de Visser, M. What we do not know about pregnancy in hereditary neuromuscular disorders. Neuromuscul Disord 2009;19:675–679.Google Scholar
Rudnik-Schoneborn, S, Schneider-Gold, C, Raabe, U, et al. Outcome and effect of pregnancy in myotonic dystrophy type 2. Neurology 2006;66:579–580.Google Scholar
Vendola, N, Matarazzo, C, Bennici, S. Myotonic dystrophy in pregnancy. Int J Gynaecol Obstet 1995;50:297–298.Google Scholar
Awater, C, Zerres, K, Rudnik-Schoneborn, S. Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol 2012;162:153–159.Google Scholar
Zaki, M, Boyd, PA, Impey, L, et al. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007;29:284–288.Google Scholar
Rudnik-Schoneborn, S, Zerres, K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004;114:44–53.Google Scholar
Ferschl M, Moxley R, Day JW, , et al. Practical Suggestions for the Anesthetic Management of a Myotonic Dystrophy Patient and Anesthesia. Quick Reference Guide. Oakland, CA: Myotonic Dystrophy Foundation; 2021.Google Scholar
van den Bersselaar, LR, Snoeck, MMJ, Gubbels, M, et al. Anaesthesia and neuromuscular disorders: what a neurologist needs to know. Pract Neurol 2020 (online). http://dx.doi.org/10.1136/practneurol-2020-002633Google Scholar
Hopkins, AN, Alshaeri, T, Akst, SA, et al. Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist. Semin Perinatol 2014;38:359–369.Google Scholar
Lee, C. Goodbye suxamethonium! Anaesthesia 2009;64(Suppl. 1):73–81.Google Scholar
Schieren, M, Defosse, J, Bohmer, A, et al. Anaesthetic management of patients with myopathies. Eur J Anaesthesiol 2017;34:641–649.Google Scholar
Gurunathan, U, Kunju, SM, Stanton, LML. Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports. BMC Anesthesiol 2019;19:213.Google Scholar
Owen, PM, Chu, C. Emergency caesarean section in a patient with myotonic dystrophy: a case of failed postoperative extubation in a patient with mild disease. Anaesth Intensive Care 2011;39:293–298.Google Scholar
Bauchat, JR, Weiniger, CF, Sultan, P, et al. Society for Obstetric Anesthesia and Perinatology Consensus Statement: Monitoring Recommendations for Prevention and Detection of Respiratory Depression Associated with Administration of Neuraxial Morphine for Cesarean Delivery Analgesia. Anesth Analg 2019;129:458–474.Google Scholar
Ogawa, K, Iranami, H, Yoshiyama, T, et al. Severe respiratory depression after epidural morphine in a patient with myotonic dystrophy. Can J Anaesth 1993;40:968–970.Google Scholar
McNally, EM, Mann, DL, Pinto, Y, et al. Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 2020;9:e014006.Google Scholar
Practice Advisory for the Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Pacemakers and Implantable Cardioverter-Defibrillators 2020: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Implantable Electronic Devices: Erratum. Anesthesiology 2020;132:938.Google Scholar
Wagner, KR. Facioscapulohumeral muscular dystrophies. Continuum (Minneap Minn) 2019;25:1662–1681.Google Scholar
Vincenten, SCC, Van Der Stoep, N, Paulussen, ADC, et al. Facioscapulohumeral muscular dystrophy: reproductive counseling, pregnancy, and delivery in a complex multigenetic disease. Clin Genet 2021 (online). https://doi.org/10.1111/cge.14031Google Scholar
Moris, G, Wood L, FernaNdez-Torro, et al. Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy. Muscle Nerve 2018;57:380–387.Google Scholar
Wohlgemuth, M, Horlings, CGC, van der Kooi, EL, et al. Respiratory function in facioscapulohumeral muscular dystrophy 1. Neuromuscul Disord 2017;27:526–530.Google Scholar
Tawil, R, Padberg, GW, Shaw, DW, et al. FSHD Workshop Participants. Clinical trial preparedness in facioscapulohumeral muscular dystrophy: clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York. Neuromuscul Disord 2016;26:181–186.Google Scholar
LoRusso, S, Johnson, NE, McDermott, MP, et al. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study. BMC Neurol 2019;19:224. https://doi.org/10.1186//s12883-019-1452-xGoogle Scholar
Rudnik-Schoneborn, S, Glauner, B, Rohrig, D, et al. Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch Neurol 1997;54:888–894.Google Scholar
Ciafaloni, E, Pressman, EK, Loi, AM, et al. Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology 2006;67:1887–1889.Google Scholar
van Dijk, GP, van der Kooi, E, Behin, A, et al. High prevalence of incomplete right bundle branch block in facioscapulohumeral muscular dystrophy without cardiac symptoms. Funct Neurol 2014;29:159–165.Google Scholar
Mah, JK, Korngut, L, Dykeman, J, et al. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2014;24:482–491.Google Scholar
Flanigan, KM. Duchenne and Becker muscular dystrophies. Neurol Clin 2014;32:671–688, viii.Google Scholar
Hoogerwaard, EM, Bakker, E, Ippel, PF, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999;353:2116–2119.Google Scholar
Ishizaki, M, Kobayashi, M, Adachi, K, et al. Female dystrophinopathy: review of current literature. Neuromuscul Disord 2018;28:572–581.Google Scholar
Politano, L, Nigro, V, Nigro, G, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996;275:1335–1338.Google Scholar
Mah, ML, Cripe, L, Slawinski, MK, et al. Duchenne and Becker muscular dystrophy carriers: evidence of cardiomyopathy by exercise and cardiac MRI testing. Int J Cardiol 2020;316:257–265.Google Scholar
Geifman-Holtzman, O, Bernstein, IM, Capeless, EL, et al. Increase in fetal breech presentation in female carriers of Duchenne muscular dystrophy. Am J Med Genet 1997;73:276–278.Google Scholar
Grimm, MJ. Forces involved with labor and delivery: a biomechanical perspective. Ann Biomed Eng 2021;49:1819–1835.Google Scholar
Georganopoulou, DG, Moisiadis, VG, Malik, FA, et al. A journey with LGMD: from protein abnormalities to patient impact. Protein J 2021;40:466–488.Google Scholar
Libell, EM, Bowdler, NC, Stephan, CM, et al. The outcomes and experience of pregnancy in limb girdle muscular dystrophy type R9. Muscle Nerve 2021;63:812–817.Google Scholar
Heller, SA, Shih, R, Kalra, R, et al. Emery-Dreifuss muscular dystrophy. Muscle Nerve 2020;61:436–448.Google Scholar
Papadimas, GK, Xirou, S, Kararizou, E, et al. Update on congenital myopathies in adulthood. Int J Mol Sci 2020;21(10):3694. https://doi.org/10.3390/ijms21103694Google Scholar
Claeys, KG. Congenital myopathies: an update. Dev Med Child Neurol 2020;62:297–302.Google Scholar
Rudnik-Schoneborn, S, Wallgren-Pettersson, C. Pregnancy and delivery in women with congenital myopathies. Semin Pediatr Neurol 2019;29:23–29.Google Scholar
Saito, O, Yamamoto, T, Mizuno, Y. Epidural anesthetic management using ropivacaine in a parturient with multi-minicore disease and susceptibility to malignant hyperthermia. J Anesth 2007;21:113.Google Scholar
Halpern, SH, Breen, TW, Campbell, DC, et al. A multicenter, randomized, controlled trial comparing bupivacaine with ropivacaine for labor analgesia. Anesthesiology 2003;98:1431–1435.Google Scholar
Jungbluth, H. Central core disease. Orphanet J Rare Dis 2007;2:25.Google Scholar
Brislin, RP, Theroux, MC. Core myopathies and malignant hyperthermia susceptibility: a review. Paediatr Anaesth 2013;23:834–841.Google Scholar
Wang, CH, Dowling, JJ, North, K, et al. Consensus statement on standard of care for congenital myopathies. J Child Neurol 2012;27:363–382.Google Scholar
Berardo, A, DiMauro, S, Hirano, M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep 2010;10:118–126.Google Scholar
Wilcox, G. Impact of pregnancy on inborn errors of metabolism. Rev Endocr Metab Disord 2018;19:13–33.Google Scholar
Karabul, N, Berndt, J, Kornblum, C, et al. Pregnancy and delivery in women with Pompe disease. Mol Genet Metab 2014;112:148–153.Google Scholar
Goker-Alpan, O, Kasturi, VG, Sohi, MK, et al. Pregnancy outcomes in late onset Pompe disease. Life (Basel) 2020;10(9):194. https://doi.org/10.3390/life10090194Google Scholar
Weida, J, Hainline, BE, Bodkin, C, et al. Management of a pregnancy complicated by Pompe disease. Case Rep Obstet Gynecol 2012;2012:137861. https://doi.org/10.1155/2012/137861Google Scholar
Rohman, PJ, Scott, E, Richfield, L, et al. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease). J Obstet Gynaecol Res 2016;42:1263–1671.Google Scholar
Plockinger, U, Tiling, N, Bosanska, L, et al. Multiple, successful pregnancies in Pompe disease. JIMD Rep 2016;28:111–118.Google Scholar
Puthenveettil, N, Issac, JS, Kadapamannil, D, et al. Anaesthetic management of caesarean section in a patient with Pompe disease. Indian J Anaesth 2021;65:418–420.Google Scholar
Dons-Sinke, IJ, Dirckx, M, Scoones, GP. Anaesthetic management of two patients with Pompe disease for caesarean section. Case Rep Anesthesiol 2014;2014:650310.Google Scholar
Cilliers, HJ, Yeo, ST, Salmon, NP. Anaesthetic management of an obstetric patient with Pompe disease. Int J Obstet Anesth 2008;17:170–173.Google Scholar
Cochrane, P, Alderman, B. Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle’s disease). J Neurol Neurosurg Psychiatry 1973;36:225–227.Google Scholar
Giles, W, Maher, C. Myophosphorylase deficiency (McArdle disease) in a patient with normal pregnancy and normal pregnancy outcome. Obstet Med 2011;4:120–121.Google Scholar
Quinlivan, R, Buckley, J, James, M, et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry 2010;81:1182–1188.Google Scholar
Stopp, T, Feichtinger, M, Eppel, W, et al. Pre- and peripartal management of a woman with McArdle disease: a case report. Gynecol Endocrinol 2018;34:736–739.Google Scholar
Coleman, P. McArdle’s disease. Problems of anaesthetic management for Caesarean section. Anaesthesia 1984;39:784–787.Google Scholar
Heller, S, Worona, L, Consuelo, A. Nutritional therapy for glycogen storage diseases. J Pediatr Gastroenterol Nutr 2008;47:S15–21.Google Scholar
McMillan, BM, Hirshberg, JS, Cosgrove, SC. McArdle disease causing rhabdomyolysis following vaginal delivery. Anaesth Rep 2019;7:73–75.Google Scholar
Gurrieri, C, Sprung, J, Weingarten, TN, et al. Patients with glycogen storage diseases undergoing anesthesia: a case series. BMC Anesthesiol 2017;17:134.Google Scholar
Bollig, G, Mohr, S, Raeder, J. McArdle’s disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Acta Anaesthesiol Scand 2005;49:1077–1083.Google Scholar
Martens, DH, Rake, JP, Schwarz, M, et al. Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 2008;198:646 e1–7.Google Scholar
Dreval, D, Bernstein, D, Zakut, H. Carnitine palmitoyl transferase deficiency in pregnancy: a case report. Am J Obstet Gynecol 1994;170:1390–1392.Google Scholar
Moundras, JM, Wattrisse, G, Leroy, B, et al. Anesthetic management of obstetrical labor in a parturient with muscular carnitine palmitoyl transferase deficiency. Ann Fr Anesth Reanim 2000;19:611–616.Google Scholar
Lilker, S, Kasodekar, S, Goldszmidt, E. Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency. Can J Anaesth 2006;53:482–486.Google Scholar
Ramsey, PS, Biggio, JR. Carnitine palmitoyltransferase deficiency in pregnancy. J Matern Fetal Neonatal Med 2005;18:357–359.Google Scholar
Wolf, A, Weir, P, Segar, P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001;357:606–607.Google Scholar
Vellekoop, P, Diekman, EF, van Tuijl, I, et al. Perioperative measures in very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab 2011;103:96–97.Google Scholar
Martin, JM, Gillingham, MB, Harding, CO. Use of propofol for short duration procedures in children with long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencies. Mol Genet Metab 2014;112:139–142.Google Scholar
Cumming, WJ, Hardy, M, Hudgson, P, et al. Carnitine-palmityl-transferase deficiency. J Neurol Sci 1976;30:247–258.Google Scholar
Katsuya, H, Misumi, M, Ohtani, Y, et al. Postanesthetic acute renal failure due to carnitine palmityl transferase deficiency. Anesthesiology 1988;68:945–948.Google Scholar
Slater, PM, Grivell, R, Cyna, AM. Labour management of a woman with carnitine palmitoyl transferase type 2 deficiency. Anaesth Intensive Care 2009;37:305–308.Google Scholar
States MHAotU. Sherburne, NY: MHAUS; 2021. Available from: www.mhaus.org/Google Scholar
Finsterer, J. Update review about metabolic myopathies. Life (Basel) 2020;10(4):43.Google Scholar
Oey, NA, den Boer, ME, Ruiter, JP, et al. High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis 2003;26:385–392.Google Scholar
Oey, NA, Ruiter, JP, Attie-Bitach, T, et al. Fatty acid oxidation in the human fetus: implications for fetal and adult disease. J Inherit Metab Dis 2006;29:71–75.Google Scholar
Mendez-Figueroa, H, Shchelochkov, OA, Shaibani, A, et al. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy. J Perinatol 2010;30:558–562.Google Scholar
Ibdah, JA, Yang, Z, Bennett, MJ. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 2000;71:182–189.Google Scholar
Yamamoto, H, Tachibana, D, Tajima, G, et al. Successful management of pregnancy with very-long-chain acyl-coenzyme A dehydrogenase deficiency. J Obstet Gynaecol Res 2015;41:1126–1128.Google Scholar
Redshaw, C, Stewart, C. Anesthetic agents in patients with very long-chain acyl-coenzyme A dehydrogenase deficiency: a literature review. Paediatr Anaesth 2014;24:1115–1119.Google Scholar
Say, RE, Whittaker, RG, Turnbull, HE, et al. Mitochondrial disease in pregnancy: a systematic review. Obstet Med 2011;4:90–94.Google Scholar
Karaa, A, Elsharkawi, I, Clapp, MA, et al. Effects of mitochondrial disease/dysfunction on pregnancy: a retrospective study. Mitochondrion 2019;46:214–220.Google Scholar
Kovilam, OP, Cahill, W, Siddiqi, TA. Pregnancy with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. Obstet Gynecol 1999;93:853.Google Scholar
de Laat, P, Fleuren, LH, Bekker, MN, et al. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome. Mitochondrion 2015;25:98–103.Google Scholar
Moriarty, KT, McFarland, R, Whittaker, R, et al. Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A>G melas mutation. J Obstet Gynaecol 2008;28:349.Google Scholar
Hosono, T, Suzuki, M, Chiba, Y. Contraindication of magnesium sulfate in a pregnancy complicated with late-onset diabetes mellitus and sensory deafness due to mitochondrial myopathy. J Matern Fetal Med 2001;10:355–356.Google Scholar
Maurtua, M, Torres, A, Ibarra, V, et al. Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review. Int J Obstet Anesth 2008;17:370–373.Google Scholar
Bell, JD, Higgie, K, Joshi, M, et al. Anesthetic management of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS Syndrome) in a high-risk pregnancy: a case report. A A Case Rep 2017;9:38–41.Google Scholar
Parikh, S, Saneto, R, Falk, MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414–430.Google Scholar
Niezgoda, J, Morgan, PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth 2013;23:785–793.Google Scholar
Gurrieri, C, Kivela, JE, Bojanic, K, et al. Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series. Can J Anaesth 2011;58:751–763.Google Scholar
Chow, SY, Woon, KL. General anesthesia for adults with mitochondrial myopathy. A A Case Rep 2015;4:52–57.Google Scholar
Ruff, RL, Shapiro, BE. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis, and related syndromes. In Katirji, BKH, Ruff, R. (Eds.), Neuromuscular Disorders in Clinical Practice. New York, NY: Springer; 2014: 1149–1185.Google Scholar
Bandschapp, O, Iaizzo, PA. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses. Paediatr Anaesth 2013;23:824–833.Google Scholar
Morton, A. Myotonic disorders and pregnancy. Obstet Med 2020;13:14–19.Google Scholar
Desaphy, JF, Altamura, C, Vicart, S, et al. Targeted therapies for skeletal muscle ion channelopathies: systematic review and steps towards precision medicine. J Neuromuscul Dis 2021;8:357–381.Google Scholar
Offord, J, Catterall, WA. Electrical activity, cAMP, and cytosolic calcium regulate mRNA encoding sodium channel alpha subunits in rat muscle cells. Neuron 1989;2:1447–1452.Google Scholar
Charles, G, Zheng, C, Lehmann-Horn, F, et al. Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals. J Neurol 2013;260:2606–2013.Google Scholar
Rudnik-Schoneborn, S, Witsch-Baumgartner, M, Zerres, K. Influences of pregnancy on different genetic subtypes of non-dystrophic myotonia and periodic paralysis. Gynecol Obstet Invest 2016;81:472–476.Google Scholar
Raja Rayan, DL, Hanna, MG. Managing pregnancy and anaesthetics in patients with skeletal muscle channelopathies. Neuromuscul Disord 2020;30:539–545.Google Scholar
Snyder, Y, Donlin-Smith, C, Snyder, E, et al. The course and outcome of pregnancy in women with nondystrophic myotonias. Muscle Nerve 2015;52:1013–1015.Google Scholar
Thiel, RE. The myotonic response to suxamethonium. Br J Anaesth 1967;39:815–821.Google Scholar
Vita, GM, Olckers, A, Jedlicka, AE, et al. Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene. Anesthesiology 1995;82:1097–1103.Google Scholar
Farbu, E, Softeland, E, Bindoff, LA. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. Acta Anaesthesiol Scand 2003;47:630–634.Google Scholar
Parness, J, Bandschapp, O, Girard, T. The myotonias and susceptibility to malignant hyperthermia. Anesth Analg 2009;109:1054–1064.Google Scholar
Farini, A, Villa, C, Tripodi, L, et al. Role of immunoglobulins in muscular dystrophies and inflammatory myopathies. Front Immunol 2021;12:666879.Google Scholar
Mariampillai, K, Granger, B, Amelin, D, et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 2018;75:1528–1537.Google Scholar
Dalakas, MC. Inflammatory muscle diseases. N Engl J Med 2015;372:1734–1747.Google Scholar
Kiely, PD, Chua, F. Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis. Curr Rheumatol Rep 2013;15:359.Google Scholar
Waseda, Y. Myositis-related interstitial lung disease: a respiratory physician’s point of view. Medicina (Kaunas) 2021;57:599.Google Scholar
Che, WI, Hellgren, K, Stephansson, O, et al. Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis: a population-based study. Rheumatology (Oxford) 2020;59:2572–2580.Google Scholar
Kolstad, KD, Fiorentino, D, Li, S, et al. Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Semin Arthritis Rheum 2018;47:865–869.Google Scholar
Martyn, JA, Richtsfeld, M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006;104:158–169.Google Scholar
Suzuki, T, Nameki, K, Shimizu, H, et al. Efficacy of rocuronium and sugammadex in a patient with dermatomyositis. Br J Anaesth 2012;108:703.Google Scholar
You, AH, Kang, HY, Park, SW, et al. Delayed recovery of limb muscle power after general anesthesia with cisatracurium in a dermatomyositis patient. J Clin Anesth 2018;50:59–60.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×